Literature DB >> 29248063

Plan responses to diagnosis-based payment: Evidence from Germany's morbidity-based risk adjustment.

Sebastian Bauhoff1, Lisa Fischer2, Dirk Göpffarth3, Amelie C Wuppermann4.   

Abstract

Many competitive health insurance markets adjust payments to participating health plans according to their enrollees' risk - including based on diagnostic information. We investigate responses of German health plans to the introduction of morbidity-based risk adjustment in the Statutory Health Insurance in 2009, which triggers payments based on "validated" diagnoses by providers. Using the regulator's data from office-based physicians, we estimate a difference-in-difference analysis of the change in the share and number of validated diagnoses for ICD codes that are inside or outside the risk adjustment but are otherwise similar. We find a differential increase in the share of validated diagnoses of 2.6 and 3.6 percentage points (3-4%) between 2008 and 2013. This increase appears to originate from both a shift from not-validated toward validated diagnoses and an increase in the number of such diagnoses. Overall, our results indicate that plans were successful in influencing physicians' coding practices in a way that could lead to higher payments.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diagnostic coding; German statutory health insurance; Health plan payment; Managed competition; Risk adjustment

Mesh:

Year:  2017        PMID: 29248063     DOI: 10.1016/j.jhealeco.2017.03.001

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  8 in total

1.  Spatial risk adjustment between health insurances: using GWR in risk adjustment models to conserve incentives for service optimisation and reduce MAUP.

Authors:  Danny Wende
Journal:  Eur J Health Econ       Date:  2019-06-13

Review 2.  Polymyalgia Rheumatica.

Authors:  Miriam Giovanna Colombo; Anna-Jasmin Wetzel; Hannah Haumann; Simon Dally; Gudula Kirtschig; Stefanie Joos
Journal:  Dtsch Arztebl Int       Date:  2022-06-17       Impact factor: 8.251

3.  Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment.

Authors:  Jens Reimer; Tobias Vogelmann; Daniel Trümper; Norbert Scherbaum
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-12-16

4.  The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization.

Authors:  Andreas Schwarting; Heiko Friedel; Elena Garal-Pantaler; Marc Pignot; Xia Wang; Henk Nab; Barnabas Desta; Edward R Hammond
Journal:  Rheumatol Ther       Date:  2021-02-05

5.  Risk of psoriatic arthritis depending on age: analysis of data from 65 million people on statutory insurance in Germany.

Authors:  Madeline Deike; Ralph Brinks; Stephan Meller; Matthias Schneider; Philipp Sewerin
Journal:  RMD Open       Date:  2021-12

6.  How to deal with persistently low/high spenders in health plan payment systems?

Authors:  Richard C van Kleef; René C J A van Vliet
Journal:  Health Econ       Date:  2022-02-08       Impact factor: 2.395

7.  Comparing risk adjustment estimation methods under data availability constraints.

Authors:  Marica Iommi; Savannah Bergquist; Gianluca Fiorentini; Francesco Paolucci
Journal:  Health Econ       Date:  2022-04-05       Impact factor: 2.395

8.  Government regulation of private health insurance.

Authors:  Nkengafac Villyen Motaze; Primus Che Chi; Pierre Ongolo-Zogo; Jean Serge Ndongo; Charles S Wiysonge
Journal:  Cochrane Database Syst Rev       Date:  2021-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.